DGAP-Ad-hoc: SYNLAB AG / Key word(s): Forecast 
SYNLAB announces upward revision of FY'21 guidance 
08-Jul-2021 / 18:38 CET/CEST 
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a 
service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
In view of better-than-expected H1'21 trading, driven by robust growth of the underlying business and 
higher-than-expected SARS-CoV-2 momentum, SYNLAB is raising its FY'21 guidance. 
Revenue is now expected to be within a range of EUR 3.2-3.3 billion in FY'21 (previously: "comfortably exceed EUR 3.0 
billion") with total growth expected within a range of 22-25% (previously: 17%) compared with FY'20. 
Adjusted EBITDA is expected to exceed EUR 925 million in FY'21 (new guidance), compared with EUR 679 million in FY'20. 
Unlevered free cash flow (pre-M&A) is expected to exceed EUR 500 million in FY'21 (previously: EUR 300-350 million) 
compared with EUR 272 million in FY'20. 
SYNLAB will publish the full H1'21 financial results and provide further details with its non-audited results on 12 
August 2021. 
Statements made in this document may include forward-looking statements. Forward-looking statements include all 
statements that are not historical facts and can be identified by the use of forward-looking terminology such as the 
words "believes," "expects," "expected," "may," "will," "would," "should," "seeks," "pro forma," "anticipates," 
"intends," "plans," "estimates," "estimated," or the negative of any thereof or other variations thereof or comparable 
terminology, or by discussions of strategy or intentions. These statements are not guarantees of future actions or 
performance and involve risks, uncertainties and assumptions as to future events that may not prove to be accurate. 
Actual actions or results may differ materially from what is expressed or forecasted in these forward-looking 
statements. As a result, these statements speak only as of the date they were made and SYNLAB undertakes no obligation 
to publicly update or revise any forward-looking statements, whether as a result of new information, future events or 
otherwise. It should be noted that past performance is not a guide to future performance. Interim results are not 
necessarily indicative of full-year results. 
Certain data included in this document (adjusted EBITDA, unlevered free cash flow) are "non-IFRS" measures. For a 
definition of these measures, please refer to SYNLAB Q1'21 press release dated 12 May 2021. 
=---------------------------------------------------------------------------------------------------------------------- 
08-Jul-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and 
Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 
Language:     English 
Company:      SYNLAB AG 
              Moosacher Straße 88 
              80809 Munich 
              Germany 
Phone:        +49 1701183753 
E-mail:       ir@synlab.com 
Internet:     www.synlab.com/ 
ISIN:         DE000A2TSL71 
WKN:          A2TSL7 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, 
              Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange 
EQS News ID:  1216972 
 
End of Announcement  DGAP News Service 
=------------

1216972 08-Jul-2021 CET/CEST


 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1216972&application_name=news

(END) Dow Jones Newswires

July 08, 2021 12:38 ET (16:38 GMT)